Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,102 | 117,774 | 129,971 | 142,090 | 160,309 |
| Receivables | 5,403 | 4,523 | 5,196 | 4,908 | 4,172 |
| Other current assets | 14,969 | 0 | 0 | 0 | 0 |
| TOTAL | $134,654 | $131,879 | $143,131 | $156,905 | $171,065 |
| Non-Current Assets | |||||
| PPE Net | 10,719 | 10,962 | 11,532 | 11,821 | 12,269 |
| Intangibles | 34,946 | 35,736 | 36,526 | 37,317 | 38,107 |
| Other Non-Current Assets | 8,370 | 8,172 | 8,293 | 8,463 | 8,529 |
| TOTAL | $54,035 | $54,870 | $56,351 | $57,601 | $58,905 |
| Total Assets | $188,689 | $186,749 | $199,482 | $214,506 | $229,970 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,076 | 2,556 | 1,162 | 1,601 | 5,145 |
| Accrued Expenses | 7,966 | 10,278 | 8,330 | 9,212 | 11,923 |
| TOTAL | $15,072 | $15,589 | $12,835 | $12,598 | $18,569 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,044 | 839 | 1,434 | N/A | N/A |
| Other Non-Current Liabilities | 13,714 | 13,892 | 14,125 | 14,336 | 14,315 |
| TOTAL | $14,156 | $14,370 | $14,631 | $14,913 | $15,798 |
| Total Liabilities | $29,228 | $29,959 | $27,466 | $27,511 | $34,367 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,228 | 39,415 | 39,033 | 38,921 | 38,565 |
| Common Shares | 87 | 87 | 87 | 87 | 87 |
| Retained earnings | -217,124 | -209,010 | -192,079 | -176,590 | -159,297 |
| Other shareholders' equity | -15,384 | -24,560 | -24,712 | -23,104 | -30,894 |
| TOTAL | $159,461 | $156,790 | $172,016 | $186,995 | $195,603 |
| Total Liabilities And Equity | $188,689 | $186,749 | $199,482 | $214,506 | $229,970 |